Recent Advances

January 7, 2013

Scientists at the Gladstone Institutes have discovered how the interplay between two proteins in the brain fuels the degradation and death of the class of brain cells, or neurons, that leads to Parkinson’s. These findings, which stand in stark contrast to conventional wisdom, lay much-needed groundwork for developing treatments that target the disease’s elusive underlying mechanisms.

December 6, 2012

Scientists at the Gladstone Institutes have identified a novel mechanism by which a type of low-carb, low-calorie diet—called a “ketogenic diet”—could delay the effects of aging. 

December 5, 2012

Gladstone Investigators Robert Mahley, MD, PhD, and Yadong Huang, MD, PhD, describe the process by which an important protein, known as apoE4, promotes the development of Alzheimer’s and recommend a renewed focus on a strategy that could fundamentally change the course of the disease’s progression.

December 4, 2012

The ALS Therapy Development Institute (ALS TDI) and the Gladstone Institutes today announced the formation of a research collaboration to speed the discovery of potential treatments for ALS through the preclinical drug development process. 

November 27, 2012

Scientists at the Gladstone Institutes have defined for the first time a key underlying process implicated in multiple sclerosis.

October 28, 2012

Scientists at the Gladstone Institutes and the Stanford University School of Medicine have discovered how modifying a gene halts the toxic buildup of a protein found in nerve cells. These findings point to a potential new tactic for treating a variety of neurodegenerative conditions, including amyotrophic lateral sclerosis (ALS, or Lou Gehrig’s disease)—a fatal disease for which there is no cure. 

October 8, 2012

Gladstone scientists have discovered how a protein deficiency may be linked to frontotemporal dementia (FTD)—a form of early-onset dementia that is similar to Alzheimer’s disease.

August 6, 2012

Scientists at the Gladstone Institutes have discovered that an FDA-approved anti-epileptic drug reverses memory loss and alleviates other Alzheimer’s-related impairments in an animal model of the disease. 

July 15, 2012

Lennart Mucke, MD, who directs neurological research at the Gladstone Institutes, has received the Khalid Iqbal Lifetime Achievement Award for his exceptional contributions to Alzheimer's disease research.

June 28, 2012

Gladstone scientists participate in an international consortium that uses stem cell technology to tackle Huntington's disease